Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today
Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today

We deliver Mobile Wallet Market Research and SWOT Analysis from Alternative Energy to Pharmaceuticals and Healthcare Market Research Reports to Digital Media.

Skip to Main Content »

Search Site
Researchers Currently Online:1257

Agenix Limited (AGX) - Financial and Strategic SWOT Analysis Review

Agenix Limited (AGX) - Financial and Strategic SWOT Analysis Review

Double click on above image to view full picture

Zoom Out
Zoom In
Additional Information
Price $125.00
Meta Description Agenix Limited (Agenix) is a biopharmaceutical company. It develops small molecule drugs and monoclonal antibody-based diagnostics for the treatment of Hepatitis-B and other diseases. The company divides its business into two segments, namely, ThromboView
Publisher GlobalData
Date of Report Dec 3, 2013
Quick Overview
Summary

Agenix Limited (Agenix) is a biopharmaceutical company. It develops small molecule drugs and monoclonal antibody-based diagnostics for the treatment of Hepatitis-B and other diseases. The company divides its business into two segments, namely, ThromboView and AGX-1009. ThromboView is a novel radio-labelled monoclonal antibody imaging agent being developed to diagnose patients suffering from acute pulmonary embolism. AGX-1009 is a reverse transcriptase inhibitor (NtRTI) prodrug of tenofovir. The company operates along with its subsidiaries in Australia, the US and China.

This comprehensive SWOT profile of Agenix Limited provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Section 1 - About the Company 4
Agenix Limited - Key Facts 4
Agenix Limited - Key Employees 5
Agenix Limited - Key Employee Biographies 6
Agenix Limited - Major Products and Services 7
Agenix Limited - Pharmaceutical Pipeline Products Data 8
Agenix Limited, Pipeline Products by Therapy Area 8
Agenix Limited, Pipeline Products by Development Phase 9
Agenix Limited - History 11
Agenix Limited - Company Statement 13
Agenix Limited - Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Section 2 – Company Analysis 20
Agenix Limited - Business Description 20
Agenix Limited - SWOT Analysis 21
SWOT Analysis - Overview 21
Agenix Limited - Strengths 21
Strength - Established Operations in China 21
Strength - Strong Intellectual Property 21
Strength - Focused R&D Activities 21
Agenix Limited - Weaknesses 21
Weakness - Legal Claims 21
Weakness - Limited Revenue Sources 22
Agenix Limited - Opportunities 22
Opportunity - Changing Demographics 22
Opportunity - SFDA Approval of YouHeDing 22
Opportunity - Emerging Markets 22
Agenix Limited - Threats 23
Threat - Rapid Technological Change 23
Threat - Competitive Pressures 23
Threat - Uncertain R&D Outcomes 23
Agenix Limited - Key Competitors 24
Section 3 – Company Financial Ratios 25
Financial Ratios - Capital Market Ratios 25
Financial Ratios - Annual Ratios 25
Performance Chart 27
Financial Performance 27
Financial Ratios - Interim Ratios 28
Financial Ratios - Ratio Charts 29
Section 4 – Company’s Lifesciences Financial Deals and Alliances 30
Agenix Limited, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 30
Agenix Limited, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 31
Agenix Limited, Recent Deals Summary 32
Section 5 – Appendix 33
Methodology 33
Ratio Definitions 33
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Agenix Limited, Key Facts 4
Agenix Limited, Key Employees 5
Agenix Limited, Key Employee Biographies 6
Agenix Limited, Major Products and Services 7
Agenix Limited, Number of Pipeline Products by Therapy Area 8
Agenix Limited, Number of Pipeline Products by Development Stage 9
Agenix Limited, Pipeline Products By Therapy Area and Development Phase 10
Agenix Limited, History 11
Agenix Limited, Subsidiaries 19
Agenix Limited, Key Competitors 24
Agenix Limited, Ratios based on current share price 25
Agenix Limited, Annual Ratios 25
Agenix Limited, Interim Ratios 28
Agenix Limited, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 30
Agenix Limited, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 31
Agenix Limited, Recent Deals Summary 32
Currency Codes 33
Capital Market Ratios 33
Equity Ratios 34
Profitability Ratios 34
Cost Ratios 35
Liquidity Ratios 35
Leverage Ratios 36
Efficiency Ratios 36

List of Figures
Agenix Limited, Pipeline Products by Therapy Area 8
Agenix Limited, Pipeline Products by Development Phase 9
Agenix Limited, Performance Chart (2008 - 2012) 27
Agenix Limited, Ratio Charts 29
Agenix Limited, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 30
Agenix Limited, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013 31




...